Search Advanced

AIMS Neuroscience

2024, Volume 11, Issue 3: 341-351. doi: 10.3934/Neuroscience.2024021
Previous Article Next Article
Research article

Cognitive effects of brief and intensive neurofeedback treatment in schizophrenia: a single center pilot study

  • 1.
    Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy
  • 2.
    Psychiatry Unit, Polyclinic Hospital University of Messina, Messina, Italy
  • 3.
    Department “Scienze della Salute”, University of Catanzaro, Catanzaro, Italy
  • 4.
    Department of Mental Health and Addictions, ASST Papa Giovanni XXIII, Bergamo, Italy
  • Received: 22 April 2024 Revised: 21 August 2024 Accepted: 02 September 2024 Published: 09 September 2024

  • Background 

    Schizophrenia is characterized by significant cognitive impairments and affects up to 98% of patients. Neurofeedback (NF) offers a means to modulate neural network function through cognitive processes such as learning and memorization, with documented structural changes in the brain, most notably an increase in grey matter volume in targeted regions.

    Methods 

    The present 2-week, open-label, preliminary study aims to evaluate the efficacy on cognition of an adjunctive short and intensive (8 daily sessions lasting 30 minutes) alpha/theta NF training in a sample of subjects affected by schizophrenia on stabilized treatment with atypical antipsychotic drugs. The efficacy was measured at baseline and at the end of the study by the Brief Neuropsychological Examination 2 (ENB 2), the Mini Mental State Examination (MMSE), and the Stroop color-word interference test; the clinical symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS).

    Results 

    A final sample of nine patients completed the study. Regarding the cognitive performance, at the final assessment (week 2), the NF treatment significantly improved the performance in the “Story Recall Immediate” (p = 0.024), “Story Recall Delayed” (p = 0.007), “Interference Memory 30 s” (p = 0.024), “Clock Test” (p = 0.014) sub-tests, and the ENB2 Total Score (p = 0.007). Concerning the clinical symptoms, no significant changes were observed in the PANSS subscales and the PANSS Total score.

    Conclusions 

    NF could represent an adjunctive treatment strategy in the therapeutic toolbox for schizophrenia cognitive symptoms.

    Citation: Fabrizio Turiaco, Fiammetta Iannuzzo, Giovanni Genovese, Clara Lombardo, Maria Catena Silvestri, Laura Celebre, Maria Rosaria Anna Muscatello, Antonio Bruno. Cognitive effects of brief and intensive neurofeedback treatment in schizophrenia: a single center pilot study[J]. AIMS Neuroscience, 2024, 11(3): 341-351. doi: 10.3934/Neuroscience.2024021

    Related Papers:

  • Background 

    Schizophrenia is characterized by significant cognitive impairments and affects up to 98% of patients. Neurofeedback (NF) offers a means to modulate neural network function through cognitive processes such as learning and memorization, with documented structural changes in the brain, most notably an increase in grey matter volume in targeted regions.

    Methods 

    The present 2-week, open-label, preliminary study aims to evaluate the efficacy on cognition of an adjunctive short and intensive (8 daily sessions lasting 30 minutes) alpha/theta NF training in a sample of subjects affected by schizophrenia on stabilized treatment with atypical antipsychotic drugs. The efficacy was measured at baseline and at the end of the study by the Brief Neuropsychological Examination 2 (ENB 2), the Mini Mental State Examination (MMSE), and the Stroop color-word interference test; the clinical symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS).

    Results 

    A final sample of nine patients completed the study. Regarding the cognitive performance, at the final assessment (week 2), the NF treatment significantly improved the performance in the “Story Recall Immediate” (p = 0.024), “Story Recall Delayed” (p = 0.007), “Interference Memory 30 s” (p = 0.024), “Clock Test” (p = 0.014) sub-tests, and the ENB2 Total Score (p = 0.007). Concerning the clinical symptoms, no significant changes were observed in the PANSS subscales and the PANSS Total score.

    Conclusions 

    NF could represent an adjunctive treatment strategy in the therapeutic toolbox for schizophrenia cognitive symptoms.



    加载中

    Acknowledgments


    The authors thank Massimo Cacciola - Psychiatry Unit, Polyclinic Hospital University of Messina, Messina, Italy – and Federica Rapisarda - University of Messina, Italy - for assistance with recruitment and data collection.

    Conflict of interest


    None.

    Funding source


    This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    Author contributions


    F.T.: Writing – original draft, Writing – review & editing. F. I.: Data curation, Formal analysis, Methodology. G. G.: Methodology, Writing – review & editing. C. L.: Methodology, Writing – review & editing. M.C.S.: Methodology, Writing – review & editing. L.C.: Data curation, Writing – review & editing. M.R.A. M.: Conceptualization, Supervision, Writing – review & editing. A.B.: Conceptualization, Formal analysis, Supervision, Writing – original draft, Writing – review & editing.

    [1] Keefe RSE, Eesley CE, Poe MP (2005) Defining a cognitive function decrement in schizophrenia. Biol Psychiatry 57: 688-691. https://doi.org/10.1016/j.biopsych.2005.01.003
    [2] Heinrichs RW, Zakzanis KK (1998) Neurocognitive Deficit in Schizophrenia: A Quantitative Review of the Evidence. Neuropsychology 12: 426-445. https://doi.org/10.1037//0894-4105.12.3.426
    [3] Green MF, Kern RS, Braff DL, et al. (2000) Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the ‘Right Stuff’?. Schizophr Bull 26: 119-136. https://doi.org/10.1093/oxfordjournals.schbul.a033430
    [4] Keefe RSE, Bilder RM, Davis SM, et al. (2007) Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial. Arch Gen Psychiatry 64: 633-647. https://doi.org/10.1001/archpsyc.64.6.633
    [5] Bon L, Franck N (2018) The impact of cognitive remediation on cerebral activity in schizophrenia: Systematic review of the literature. Brain Behav 8: e00908. https://doi.org/10.1002/brb3.908
    [6] Marzbani H, Marateb HR, Mansourian M (2016) Methodological note: Neurofeedback: A comprehensive review on system design, methodology and clinical applications. Basic Clin Neurosci 7: 143-158. https://doi.org/10.15412/J.BCN.03070208
    [7] Markiewicz R (2017) The use of EEG biofeedback/neurofeedback in psychiatric rehabilitation. Psychiatr Pol 51: 1095-1106. https://doi.org/10.12740/PP/68919
    [8] Schabus M, Griessenberger H, Gnjezda MT, et al. (2017) Better than sham? A double-blind placebo-controlled neurofeedback study in primary insomnia. Brain 140: 1041-1052. https://doi.org/10.1093/brain/awx011
    [9] Coben R, Evans RJ (2010) Neurofeedback and Neuromodulation Techniques and Applications.Academic Press.
    [10] Angelakis E, Stathopoulou S, Frymiare JL, et al. (2007) EEG neurofeedback: A brief overview and an example of peak alpha frequency training for cognitive enhancement in the elderly. Clin Neuropsychol 21: 110-129. https://doi.org/10.1080/13854040600744839
    [11] Lecomte G, Juhel J (2011) The Effects of Neurofeedback Training on Memory Performance in Elderly Subjects. Psychology 02: 846-852. https://doi.org/10.4236/psych.2011.28129
    [12] Gruzelier JH (2014) EEG-neurofeedback for optimising performance. I: A review of cognitive and affective outcome in healthy participants. Neurosci Biobehav Rev 44: 124-141. https://doi.org/10.1016/j.neubiorev.2013.09.015
    [13] Reis J, Portugal AM, Fernandes L, et al. (2016) An alpha and theta intensive and short neurofeedback protocol for healthy aging working-memory training. Front Aging Neurosci 8: 157. https://doi.org/10.3389/fnagi.2016.00157
    [14] Niv S (2013) Clinical efficacy and potential mechanisms of neurofeedback. Pers Individ Dif 54: 676-686. https://doi.org/10.1016/j.paid.2012.11.037
    [15] Surmeli T, Ertem A, Eralp E, et al. (2012) Schizophrenia and the efficacy of qEEG-guided neurofeedback treatment: A clinical case series. Clin EEG Neurosci 43: 133-144. https://doi.org/10.1177/1550059411429531
    [16] Gruzelier J, Hardman E, Wild J, et al. (1999) Learned control of slow potential interhemispheric asymmetry in schizophrenia. Int J Psychophysiol 34: 341-348. https://doi.org/10.1016/s0167-8760(99)00091-4
    [17] Bolea AS (2010) Neurofeedback treatment of chronic inpatient schizophrenia. J Neurother 14: 47-54. https://doi.org/10.1080/10874200903543971
    [18] Cordes JS, Mathiak KA, Dyck M, et al. (2015) Cognitive and neural strategies during control of the anterior cingulate cortex by fMRI neurofeedback in patients with schizophrenia. Front Behav Neurosci 9: 169. https://doi.org/10.3389/fnbeh.2015.00169
    [19] Rieger K, Rarra MH, Diaz Hernandez L, et al. (2018) Neurofeedback-Based Enhancement of Single-Trial Auditory Evoked Potentials: Treatment of Auditory Verbal Hallucinations in Schizophrenia. Clin EEG Neurosci 49: 79-92. https://doi.org/10.1177/1550059417708935
    [20] Singh F, Shu IW, Hsu SH, et al. (2020) Modulation of frontal gamma oscillations improves working memory in schizophrenia. Neuroimage Clin 27: 102339. https://doi.org/10.1016/j.nicl.2020.102339
    [21] Markiewicz R, Markiewicz-Gospodarek A, Dobrowolska B, et al. (2021) Improving Clinical, Cognitive, and Psychosocial Dysfunctions in Patients with Schizophrenia: A Neurofeedback Randomized Control Trial. Neural Plast 2021: 4488664. https://doi.org/10.1155/2021/4488664
    [22] Zweerings J, Hummel B, Keller M, et al. (2019) Neurofeedback of core language network nodes modulates connectivity with the default-mode network: A double-blind fMRI neurofeedback study on auditory verbal hallucinations. Neuroimage 189: 533-542. https://doi.org/10.1016/j.neuroimage.2019.01.058
    [23] Orlov ND, Giampietro V, O'Daly O, et al. (2018) Real-time fMRI neurofeedback to down-regulate superior temporal gyrus activity in patients with schizophrenia and auditory hallucinations: A proof-of-concept study. Transl Psychiatry 8: 46. https://doi.org/10.1038/s41398-017-0067-5
    [24] Balconi M, Frezza A, Vanutelli ME (2018) Emotion Regulation in Schizophrenia: A Pilot Clinical Intervention as Assessed by EEG and Optical Imaging (Functional Near-Infrared Spectroscopy). Front Hum Neurosci 12: 395. https://doi.org/10.3389/fnhum.2018.00395
    [25] Schneider F, Rockstroh B, Heimann H, et al. (1992) Self-Regulation of Slow Cortical Potentials in Psychiatric Patients: Schizophrenia. Biofeedback Self-regulation 17: 277-292. https://doi.org/10.1007/BF01000051
    [26] Lin Y, Shu IW, Hsu SH, et al. (2022) Novel EEG-Based Neurofeedback System Targeting Frontal Gamma Activity of Schizophrenia Patients to Improve Working Memory. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS.Institute of Electrical and Electronics Engineers Inc. 4031-4035. https://doi.org/10.1109/EMBC48229.2022.9870878
    [27] Mondini S, Montemurro S, Pucci V, et al. (2022) Global Examination of Mental State: An open tool for the brief evaluation of cognition. Brain Behav 12: e2710. https://doi.org/10.1002/brb3.2710
    [28] Baek MJ, Kim K, Park YH, et al. (2016) The validity and reliability of the mini-mental state examination-2 for detecting mild cognitive impairment and Alzheimer's disease in a Korean population. PLoS One 11: e0163792. https://doi.org/10.1371/journal.pone.0163792
    [29] Periáñez JA, Lubrini G, García-Gutiérrez A, et al. (2021) Construct validity of the stroop color-word test: Influence of speed of visual search, verbal fluency, working memory, cognitive flexibility, and conflict monitoring. Arch Clin Neuropsych 36: 99-111. https://doi.org/10.1093/arclin/acaa034
    [30] Edgar CJ, Blaettler T, Bugarski-Kirola D, et al. (2014) Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptoms. Psychiatry Res 218: 219-224. https://doi.org/10.1016/j.psychres.2014.04.009
    [31] Pazooki K, Leibetseder M, Renner W, et al. (2019) Neurofeedback Treatment of Negative Symptoms in Schizophrenia: Two Case Reports. Appl Psychophys Biof 44: 31-39. https://doi.org/10.1007/s10484-018-9417-1
    [32] Nan W, Wan F, Chang L, et al. (2017) An Exploratory Study of Intensive Neurofeedback Training for Schizophrenia. Behav Neurol 2017: 6914216. https://doi.org/10.1155/2017/6914216
    [33] Gomes JS, Ducos DV, Gadelha A, et al. (2018) Hemoencephalography self-regulation training and its impact on cognition: A study with schizophrenia and healthy participants. Schizophr Res 195: 591-593. https://doi.org/10.1016/j.schres.2017.08.044
  • Reader Comments
  • © 2024 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
AIMS Neuroscience
3.1 4.2

Metrics

Article views(342) PDF downloads(33) Cited by(0)

Preview PDF
Download XML
Export Citation
Article outline

Figures and Tables

Tables(3)

Other Articles By Authors

Related pages

Tools

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog